Amryt Pharma

• NCT04681170

  Phase 3, Completed, 46 people, 23 Dec 2020

• Gaps in lipid management among high-risk patients without prior MI or stroke: the VESALIUS-REAL global study

  Consulting or advice, Fees or honoraria, Grants or research support, 3 Sept 2026

• The prevention of adult cardiovascular disease must begin in childhood: evidence and imperative

  Consulting or advice, 12 Sept 2025

Sources: pubmed.ncbi.nlm.nih.gov

• Adipose-Tissue Insulin Resistance Predicts Mortality in Persons at Risk for Cardiac Diseases

  ADA Scientific Sessions 2025 abstract, 13 Jun 2025